tiprankstipranks
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
Holding ADVM?
Track your performance easily

Adverum Biotechnologies (ADVM) Financial Statements

591 Followers

Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently ―. The company's EPS TTM is $-6.033; its P/E ratio is -1.02; Adverum Biotechnologies is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-1.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 1.00M----
Gross Profit$ 1.00M----
EBIT$ -27.13M$ -18.48M$ -24.79M$ -23.79M$ -32.87M
EBITDA$ -25.70M$ -16.66M$ -23.62M$ -22.22M$ -25.83M
Net Income Common Stockholders$ -27.13M$ -18.48M$ -24.79M$ -23.71M$ -32.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 153.24M$ 173.83M$ 193.33M$ 96.53M$ 117.08M
Total Assets$ 234.38M$ 253.80M$ 267.83M$ 173.01M$ 196.77M
Total Debt$ 73.26M$ 73.89M$ 74.48M$ 75.04M$ 75.52M
Net Debt$ -79.98M$ -99.94M$ -118.84M$ -21.49M$ -41.56M
Total Liabilities$ 90.26M$ 85.77M$ 85.54M$ 89.54M$ 94.06M
Stockholders Equity$ 144.12M$ 168.03M$ 182.29M$ 83.47M$ 102.71M
Cash Flow-
Free Cash Flow$ -21.34M$ -19.86M$ -23.34M$ -21.52M$ -24.41M
Operating Cash Flow$ -21.12M$ -19.84M$ -23.25M$ -21.33M$ -23.91M
Investing Cash Flow$ -13.35M$ -2.33M$ -22.03M$ -9.88M$ 18.20M
Financing Cash Flow-$ -116.00K$ 119.88M$ 166.00K$ -105.00K
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis